Home > Insider Trading > Filing (0001562180-21-007876)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1590877	Regenxbio Inc.	RGNX	Biological Products, (No Disgnostic Substances) (2836)	471851754

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1652936	M. Allan Fox	C/O Regenxbio Inc. 9804 Medical Center Drive Rockville MD 20850		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-12-22	61,638	$34.40	1,581,212	No	4	S	Indirect	By Quaker Gray LLC
Common Stock	Disposition	2021-12-23	44,908	$34.92	1,536,304	No	4	S	Indirect	By Quaker Gray LLC
Common Stock	Disposition	2021-12-23	6,323	$35.85	1,529,981	No	4	S	Indirect	By Quaker Gray LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Quaker Gray LLC
No	4	S	Indirect	By Quaker Gray LLC
No	4	S	Indirect	By Quaker Gray LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	722,485	Indirect	By AMF Family Gift Trust LLC
Common Stock	315,000	Indirect	By AMF Gift Trust LLC
Common Stock	315,000	Indirect	By HBF Gift Trust LLC

Footnotes

This transaction was executed in multiple trades at prices ranging from $34.01 to $34.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
This transaction was executed in multiple trades at prices ranging from $34.75 to $35.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $35.75 to $36.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.